{"schema_version":"secwatch.filing_event.v1","accession":"0001815776-26-000041","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2026-06-12T20:08:05+00:00","discovered_at":"2026-06-12T20:09:00.201532+00:00","generated_at":"2026-06-12T20:21:08.333010+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"LENZ Therapeutics shareholders elect three Class II directors and ratify auditor at 2026 annual meeting.","bullets":["Votes for Evert Schimmelpennink: 20,216,637; withheld: 230,219; broker non-votes: 3,995,212.","Votes for Jeff George: 13,462,359; withheld: 6,984,497; broker non-votes: 3,995,212.","Votes for Shelley Thunen: 20,215,686; withheld: 231,170; broker non-votes: 3,995,212.","Ratification of Ernst & Young as auditor passed: 24,310,915 for, 55,181 against, 75,972 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001815776-26-000041","json":"https://secwatch.observer/filing/0001815776-26-000041.json","markdown":"https://secwatch.observer/filing/0001815776-26-000041.md","text":"https://secwatch.observer/filing/0001815776-26-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/0001815776-26-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/lenz-20260612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:21:08.333010+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba6c4753fd05ffed7c536836f6ecec842b66cf93","claim":"LENZ Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-12 meeting.","evidence_excerpt":"Votes For Votes Against Abstentions Broker Non-Votes 24,310,915 55,181 75,972 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/0001815776-26-000041-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-12"}],"fact_type":"shareholder_vote"},{"claim_id":"eee31ab0ba1beb677c38bec254624be536c8dcf4","claim":"LENZ Therapeutics, Inc. shareholders approved Election of Class II Directors at the 2026-06-12 meeting.","evidence_excerpt":"Nominee Votes For Votes Withheld Broker Non-Votes Evert Schimmelpennink 20,216,637 230,219 3,995,212 Jeff George 13,462,359 6,984,497 3,995,212 Shelley Thunen 20,215,686 231,170 3,995,212","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577626000041/0001815776-26-000041-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-12"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}